OmniInsight™ for Coronary Artery Disease (OI-CAD™) (PRS + Monogenic)

OmniInsight™ for Coronary Artery Disease (OI-CAD™) (PRS + Monogenic)

$1,900.00

A Breakthrough Saliva Genetic Test for Heart Disease Risk

Discover your inherited risk for Coronary Artery Disease (CAD) through an advanced saliva-based genetic test that analyzes both Polygenic Risk Scores (PRS) and Monogenic
Mutations.
Results in 4–8 weeks

Test Highlights:

  • PRS Indication: Coronary Artery Disease (CAD)
  • Monogenic Genes (FH): LDLR, APOB, PCSK9, LDLRAP1
  • Comprehensive Report: Includes your personalized risk score, interpretation, and prevention recommendations
  •  Free Virtual Consultation: One-on-one session with a genetic counselor to explain your results and next steps

Price Includes:
A complete Comprehensive Genomic Risk Test, detailed risk report, virtual counseling for
individuals with above-average or high risk, and a personalized prevention roadmap designed to
help you take proactive steps for your heart health.

Exclusive Access:
Gain access to Avigena’s OmniInsight™ (OI™) Integrated Genomic Intelligence Platform, which combines Monogenic and Polygenic Risk Scores (PRS) with clinical and lifestyle data to deliver a holistic, personalized risk assessment and actionable prevention strategy.

Code: AVI-OI-CAD™ Category:

"Prevent a Heart Attack, Before It Starts."

Simple DNA Saliva Test To Uncover Your Inherited Risk For Coronary Artery Disease

Validated across diverse ancestry and tailored to the Arab and Middle Eastern population

What Is A Polygenic Score?

  • Everyone has small genetic differences, called variants.
  • These variants can affect the risk of developing certain diseases.
  • A polygenic risk score (PRS) combines the effects of millions of genetic variants to estimate your disease risk.
  • While each variant has a small effect, their combined impact can be significant.
Know More

WHO SHOULD TAKE THIS TEST?

Adults (18-79 years)

  • Seeking personalized strategies for heart disease prevention
  • With a family history of coronary artery disease (CAD)
  • With limited or unknown family history
  • Who developed CAD despite lacking traditional risk factors

Adults (40–79 years)

  • With borderline or intermediate risk for heart disease
  • Who may benefit from knowing their genetic predisposition

Special Pediatric Group (Ages 10–18)

  • With an early family history of CAD
  • Diagnosed with familial hypercholesterolemia (FH)
  • Living with obesity, diabetes, chronic illness, or others
  • Available upon special request

Why PRS for CAD Matters

The Polygenic Risk Score (PRS) for CAD is a revolutionary genetic test that helps identify your inherited risk of heart disease, even before traditional risk factors like high cholesterol, diabetes, or high blood pressure appear.

Many heart attacks happen with no warning signs. PRS helps you act early.

It detects risk even when traditional factors (like cholesterol or blood pressure) are normal.

Even if you feel healthy today, your genes may carry silent risks that only a PRS can detect.

PRS is not a diagnosis but a powerful tool for personalized prevention.

How It Works - Step By Step

The test is powered by the innovative Blended Genome Exome™ technology, developed in collaboration with Broad Clinical Labs at Harvard University and the Massachusetts Institute of Technology.

The technology combines 95.5× whole-exome sequencing (WES) with genome-wide low-coverage whole-genome sequencing (lcWGS) to detect both rare pathogenic variants and polygenic risk with high analytical precision.

Testing is performed through CAP/CLIA accredited laboratories, with advanced analytics support from Allelica and the Laboratory for Molecular Medicine (Mass General Brigham), and regional collaboration with Novo Genomics.

 

Order Now

Equipped with one of the most precise and comprehensive genomic risk assessments available, the test integrates monogenic and polygenic risk into a single, clinically actionable report.

Results are ready in 4 to 8 weeks, enabling you to act early and make informed, proactive health decisions. 

[email protected]